The Symposium is focused on the new modality of multiple sclerosis treatment– immunosuppressive therapy followed by autologous stem cell transplantation. Centers in Europe, North and South America, Russia, China, Israel and Australia have successfully performed this procedure, and, to date, more than 600 stem cell transplantations in multiple sclerosis have been performed worldwide.

Along with promising results there are a number of unclear and challenging issues that are worth studying.

The Symposium intends to share the newly acquired knowledge in the field, to discuss the challenges and perspectives of the method, and to develop collaborative projects. The topics to be covered within the symposium include:

• Regimens of conditioning: Immunoablation or immunosupression?
• Types of transplantation: autologous or allogenic?
• Posttransplant immunological reconstitution
• Side effects
• Outcome measures: clinical, imaging, patient-reported outcomes
• Posttransplant neurorehabilitation
• Long-term follow-up results
• Proposal for cooperative studies

We invite the submission of abstracts on the above aspects of stem cell transplantation in multiple sclerosis. All abstracts will be reviewed by an international committee and a number of abstracts will be selected for oral presentation within the Symposium.

www.stemcellms.ru